Trinity Biotech Angiotensin Converting Enzyme (ACE) Reagent - Taiwan Registration 7f10256509ad4e663f115bbfc7c0fe9e
Access comprehensive regulatory information for Trinity Biotech Angiotensin Converting Enzyme (ACE) Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7f10256509ad4e663f115bbfc7c0fe9e and manufactured by TRINITY BIOTECH PLC. The authorized representative in Taiwan is BioChain Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
7f10256509ad4e663f115bbfc7c0fe9e
Ministry of Health Medical Device Import No. 025526
DHA05602552602
Product Details
A Clinical chemistry and clinical toxicology
A1090 Angioconstrictin conversion test system
Imported from abroad
Dates and Status
Oct 04, 2013
Oct 04, 2018
Jun 16, 2022
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆๆช็ณ่ซๅฑๅปถ